Karolinska Investment Fund

Karolinska Development is a leading Nordic life science investment company focused on identifying and commercializing innovative medical breakthroughs. The company creates value by investing in and developing a diversified portfolio of companies that translate high-quality science into products that can improve patient health and generate returns for shareholders. Based in Solna, Sweden, it maintains a close relationship with the Karolinska Institutet and other world-class research institutions to source early-stage opportunities. Its portfolio spans various therapeutic areas, including oncology, infectious diseases, and cardiovascular health, with a focus on both therapeutics and medical technology.